TriSalus Life Sciences, Inc.
TLSICIK 0001826667 · last filing Jul 6, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
4,551 bought / 14,650 sold
net −10,099 sh · −$47.7K
- buys
- 2
- sells
- 1
- insiders active
- 3
Filing tape
Filed Mon, Jul 6, 2026
- −14,650 sh · $65.3K
Patience David — Chief Financial Officer
- Withheld for tax14,650Common Stock@ $4.46→ 261,107 held
Filed Wed, Jul 1, 2026
- +3,990 sh · $15.4K
Szela Mary T — CEO and President · Director
- Granted3,990Common Stock@ $3.87→ 1,077,683 held
- +561 sh · $2.2K
Marshak Richard — Chief Commercial Officer
- Granted561Common Stock@ $3.87→ 128,319 held
Insiders on this tape
- Patience DavidChief Financial Officer
- Szela Mary TCEO and President · Director
- Marshak RichardChief Commercial Officer
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.